Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?
3
Neuropsychiatry Program, Department of Psychiatry & Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, Brazil
|
Publication type: Journal Article
Publication date: 2020-11-26
scimago Q1
wos Q1
SJR: 1.255
CiteScore: 7.2
Impact factor: 4.4
ISSN: 14728222, 17447631
PubMed ID:
33141605
Drug Discovery
Pharmacology
Clinical Biochemistry
Molecular Medicine
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
International Journal of Molecular Sciences
2 publications, 4.88%
|
|
|
Frontiers in Behavioral Neuroscience
2 publications, 4.88%
|
|
|
Translational Psychiatry
2 publications, 4.88%
|
|
|
Doklady Biochemistry and Biophysics
2 publications, 4.88%
|
|
|
Gigiena i sanitariia
2 publications, 4.88%
|
|
|
Anais Brasileiros de Dermatologia
1 publication, 2.44%
|
|
|
Pharmaceutics
1 publication, 2.44%
|
|
|
International Journal of Polymeric Materials and Polymeric Biomaterials
1 publication, 2.44%
|
|
|
Medical academic journal
1 publication, 2.44%
|
|
|
PeerJ
1 publication, 2.44%
|
|
|
Journal of Natural Medicines
1 publication, 2.44%
|
|
|
Frontiers in Pharmacology
1 publication, 2.44%
|
|
|
Mendeleev Communications
1 publication, 2.44%
|
|
|
Molecular Psychiatry
1 publication, 2.44%
|
|
|
Biomedicines
1 publication, 2.44%
|
|
|
Parkinsonism and Related Disorders
1 publication, 2.44%
|
|
|
Frontiers in Immunology
1 publication, 2.44%
|
|
|
Физиология человека
1 publication, 2.44%
|
|
|
Diabetes Research and Clinical Practice
1 publication, 2.44%
|
|
|
Human Physiology
1 publication, 2.44%
|
|
|
Russian Neurological Journal
1 publication, 2.44%
|
|
|
Anais Brasileiros de Dermatologia (Versão em Português)
1 publication, 2.44%
|
|
|
Molecular Neurobiology
1 publication, 2.44%
|
|
|
Nature Communications
1 publication, 2.44%
|
|
|
Pharmacokinetics and Pharmacodynamics (Farmakokinetika i farmakodinamika)
1 publication, 2.44%
|
|
|
Communications Medicine
1 publication, 2.44%
|
|
|
Physiology and Behavior
1 publication, 2.44%
|
|
|
Neuroscience
1 publication, 2.44%
|
|
|
Medical Sciences
1 publication, 2.44%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
|
|
|
Springer Nature
7 publications, 17.07%
|
|
|
Elsevier
7 publications, 17.07%
|
|
|
MDPI
5 publications, 12.2%
|
|
|
Frontiers Media S.A.
4 publications, 9.76%
|
|
|
Pleiades Publishing
3 publications, 7.32%
|
|
|
Federal Scientific Center for Hygiene F.F.Erisman
2 publications, 4.88%
|
|
|
IntechOpen
2 publications, 4.88%
|
|
|
Taylor & Francis
1 publication, 2.44%
|
|
|
Eco-Vector LLC
1 publication, 2.44%
|
|
|
PeerJ
1 publication, 2.44%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2.44%
|
|
|
Research Square Platform LLC
1 publication, 2.44%
|
|
|
The Russian Academy of Sciences
1 publication, 2.44%
|
|
|
Medical Informational Agency Publishers
1 publication, 2.44%
|
|
|
Publishing House OKI
1 publication, 2.44%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 2.44%
|
|
|
Wiley
1 publication, 2.44%
|
|
|
1
2
3
4
5
6
7
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
41
Total citations:
41
Citations from 2025:
14
(34.15%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
De Miranda A. S. et al. Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety? // Expert Opinion on Therapeutic Targets. 2020. Vol. 24. No. 12. pp. 1225-1238.
GOST all authors (up to 50)
Copy
De Miranda A. S., De Barros J. L. V. M., Teixeira A. Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety? // Expert Opinion on Therapeutic Targets. 2020. Vol. 24. No. 12. pp. 1225-1238.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/14728222.2020.1846720
UR - https://doi.org/10.1080/14728222.2020.1846720
TI - Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?
T2 - Expert Opinion on Therapeutic Targets
AU - De Miranda, A S
AU - De Barros, J L V M
AU - Teixeira, Antonio L.
PY - 2020
DA - 2020/11/26
PB - Taylor & Francis
SP - 1225-1238
IS - 12
VL - 24
PMID - 33141605
SN - 1472-8222
SN - 1744-7631
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_De Miranda,
author = {A S De Miranda and J L V M De Barros and Antonio L. Teixeira},
title = {Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?},
journal = {Expert Opinion on Therapeutic Targets},
year = {2020},
volume = {24},
publisher = {Taylor & Francis},
month = {nov},
url = {https://doi.org/10.1080/14728222.2020.1846720},
number = {12},
pages = {1225--1238},
doi = {10.1080/14728222.2020.1846720}
}
Cite this
MLA
Copy
De Miranda, A. S., et al. “Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?.” Expert Opinion on Therapeutic Targets, vol. 24, no. 12, Nov. 2020, pp. 1225-1238. https://doi.org/10.1080/14728222.2020.1846720.